tradingkey.logo
tradingkey.logo
Search

Corcept Therapeutics Inc

CORT
Add to Watchlist
114.860USD
+3.050+2.73%
Close 09-17 16:00ET
12.39BMarket Cap
250.75P/E TTM
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D

Today

+2.73%

5 Days

-0.05%

1 Month

-1.97%

6 Months

+242.76%

Year to Date

+230.06%

1 Year

+52.78%

Key Figures

113.180Open
115.060High
38.46KVolume
250.75P/E TTM
20.85P/E Dynamic
--Dividend TTM
0.04%Turnover Ratio
111.810Prev. Close
111.100Low
4.35MTurnover
87.77P/E Static
17.56P/B
0.00%Div Yield TTM
5.70%ROA
126.38352wk High
0.04Volume Ratio
141.21MNet Profit
107.92MShares
0.4580EPS TTM
0.46Beta
7.17%ROE
28.66052wk Low
3.54%Amplitude
98.35%Gross Margin
12.39BMarket Cap
7.29Reward/Risk
5.17%Risk Rate
More news coming soon, stay tuned...

Corcept Therapeutics Inc's Score

-0.02vs previous score
Forecast7.33
Financial Health8.81
Technical3.49
Valuation Dimensions7.15
Institutional Confidence7.00
Risk Assessment4.69

Media Coverage

Coverage Level

Very Low
Very High
Positive

Analyst Rating

Strong Buy
Buy
Hold
Sell
Strong Sell
BuyCurrent Rating
138.808Target Price
+25.26%Upside Space
Current Rating2026-092026-082026-072026-062026-052026-042026-032026-02
Strong Buy11000000
Buy44554444
Hold00112211
Sell00000000
Strong Sell11000011

Corcept Therapeutics Inc Technical Analysis

1m
5m
15m
30m
1h
2h
4h
D
W
M
1m
5m
15m
D

Technical Indicators

Buy

Summary

Buy

Moving Average

Strong buy

Financial Indicators

Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.

Earnings

Next reporting date
--
Reporting Period
2026Q2
Earnings / Forecast
0.41/0.01
Revenue / Forecast
256.15M/221.82M

Corcept Therapeutics Inc Profile

SectorPharmaceuticals
Ticker SymbolCORT
Number of employees500
CountryUnited States of America

Ownership

ShareholdersProportion
BlackRock Institutional Trust Company, N.A.10.29%
Ingalls & Snyder LLC (Asset Management)6.70%
Renaissance Technologies LLC5.36%
Baker (George Leonard Jr.)5.17%
Shareholder TypesProportion
Investment Advisor39.82%
Investment Advisor/Hedge Fund20.06%
Individual Investor11.79%
Hedge Fund8.15%

FAQs

What is the current price of Corcept Therapeutics Inc (CORT)?

The current price of Corcept Therapeutics Inc (CORT) is 114.86.

What is the symbol of Corcept Therapeutics Inc?

The ticker symbol of Corcept Therapeutics Inc is CORT.

What is the 52-week high of Corcept Therapeutics Inc?

The 52-week high of Corcept Therapeutics Inc is 126.38.

What is the 52-week low of Corcept Therapeutics Inc?

The 52-week low of Corcept Therapeutics Inc is 28.66.

What is the market capitalization of Corcept Therapeutics Inc?

The market capitalization of Corcept Therapeutics Inc is 12.39B.

Is Corcept Therapeutics Inc (CORT) currently rated as Buy, Hold, or Sell?

According to analysts, Corcept Therapeutics Inc (CORT) has an overall rating of Buy, with a price target of 138.81.

What is the Earnings Per Share (EPS TTM) of Corcept Therapeutics Inc (CORT)?

The Earnings Per Share (EPS TTM) of Corcept Therapeutics Inc (CORT) is 0.46.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.